chr6-10529216-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_145649.5(GCNT2):āc.305C>Gā(p.Thr102Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00934 in 1,614,172 control chromosomes in the GnomAD database, including 119 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0079 ( 16 hom., cov: 32)
Exomes š: 0.0095 ( 103 hom. )
Consequence
GCNT2
NM_145649.5 missense
NM_145649.5 missense
Scores
4
11
Clinical Significance
Conservation
PhyloP100: 2.63
Genes affected
GCNT2 (HGNC:4204): (glucosaminyl (N-acetyl) transferase 2 (I blood group)) This gene encodes the enzyme responsible for formation of the blood group I antigen. The i and I antigens are distinguished by linear and branched poly-N-acetyllactosaminoglycans, respectively. The encoded protein is the I-branching enzyme, a beta-1,6-N-acetylglucosaminyltransferase responsible for the conversion of fetal i antigen to adult I antigen in erythrocytes during embryonic development. Mutations in this gene have been associated with adult i blood group phenotype. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0067899227).
BP6
Variant 6-10529216-C-G is Benign according to our data. Variant chr6-10529216-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 1182271.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00792 (1206/152310) while in subpopulation SAS AF= 0.0176 (85/4828). AF 95% confidence interval is 0.0146. There are 16 homozygotes in gnomad4. There are 597 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 16 BG,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCNT2 | NM_145649.5 | c.305C>G | p.Thr102Ser | missense_variant | 3/5 | ENST00000495262.7 | NP_663624.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCNT2 | ENST00000495262.7 | c.305C>G | p.Thr102Ser | missense_variant | 3/5 | 2 | NM_145649.5 | ENSP00000419411 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00792 AC: 1206AN: 152192Hom.: 16 Cov.: 32
GnomAD3 genomes
AF:
AC:
1206
AN:
152192
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00947 AC: 2381AN: 251454Hom.: 29 AF XY: 0.0103 AC XY: 1396AN XY: 135896
GnomAD3 exomes
AF:
AC:
2381
AN:
251454
Hom.:
AF XY:
AC XY:
1396
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00949 AC: 13867AN: 1461862Hom.: 103 Cov.: 33 AF XY: 0.00980 AC XY: 7126AN XY: 727238
GnomAD4 exome
AF:
AC:
13867
AN:
1461862
Hom.:
Cov.:
33
AF XY:
AC XY:
7126
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00792 AC: 1206AN: 152310Hom.: 16 Cov.: 32 AF XY: 0.00802 AC XY: 597AN XY: 74470
GnomAD4 genome
AF:
AC:
1206
AN:
152310
Hom.:
Cov.:
32
AF XY:
AC XY:
597
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
30
ALSPAC
AF:
AC:
44
ESP6500AA
AF:
AC:
9
ESP6500EA
AF:
AC:
99
ExAC
AF:
AC:
1204
Asia WGS
AF:
AC:
21
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 09, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
GCNT2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 05, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
N;N;N
PROVEAN
Uncertain
N;N
REVEL
Benign
Sift4G
Uncertain
D;D
Polyphen
B;B
Vest4
MutPred
Loss of methylation at K105 (P = 0.1031);Loss of methylation at K105 (P = 0.1031);
MVP
MPC
0.046
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at